A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials

Pharmaceutical Statistics

Volumn 13, Issue 3, 2014, Pages 163-172

  Bowden, J ^a   Mander, A ^a  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

conditional power; median unbiased estimation; sample size re estimation; two stage trial

Indexed keywords

ANALGESIA; ARTICLE; CLINICAL EFFECTIVENESS; FUNDING; HUMAN; KNEE OSTEOARTHRITIS; LSW METHOD; MATHEMATICAL ANALYSIS; METHODOLOGY; PROFESSIONAL STANDARD; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS; PROCEDURES;

DATA INTERPRETATION, STATISTICAL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE;

EID: 84901187825     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1613     Document Type: Article

References (22)

1. US Food and Drug Administration. Guidance for Industry: Adaptive Design Clincal Trials for Drugs and Biologics, 2010. Available from: http://www.fda.gov/downloads/Drugs/./Guidances/ucm201790.pdf.
2. Gould AL, Shih W,. Modifying the design of ongoing trials without unblinding. Statistics in Medicine 1998; 17: 89-100.
3. Kieser M, Friede T,. Simple procedures for blinded sample size adjustment that do not effect the type I error rate. Statistics in Medicine 2003; 22: 3571-3581.
4. Bauer P, Kohne K,. Evaluation of experiments with adaptive interim analysis. Biometrics 1994; 50: 1029-1041.
5. Fisher L,. Self-designing clinical trials. Statistics in Medicine 1998; 17: 1551-1562.
6. Jennison C, Turnbull BW,. Mid-course sample size modification in clinical trials based on the observed treatment effect. Statistics in Medicine 2003; 22: 971-993.
7. Jennison C, Turnbull B,. Adaptive and nonadaptive group sequential tests. Biometrika 2006; 93: 1-21.
8. Proschan M, Hunsberger S,. Designed extension of studies based on conditional power. Biometrics 1995; 51: 1315-1324.
9. Li G, Shih W, Xie T,. A sample size adjustment procedure for clinical trials based on conditional power. Biostatistics 2002; 3: 277-287.
10. Wang Y, Li G, Shih W,. Estimation and confidence intervals for two-stage sample size flexible design with lsw likelihood approach. Statistics in Biosciences 2010; 2: 180-190.
11. Zhang W, Nuki G, Moskowitz R, Abramson S, Altman R, Arden N, Bierma-Zeinstra S, Brandt K, Croft P, Doherty M, Dougados M, Hochberg M, Hunter D, Kwoh K, Lohmander L, Tugwell P,. Oarsi recommendations for the management of hip and knee osteoarthritis: part iii: Changes in evidence following systematic cumulative update of research published through january 2009. Osteoarthritis Cartilage 2010; 18: 476-499.
12. Graf A, Bauer P,. Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look. Statistics in Medicine 2011; 30: 1637-1647.
13. Li G, Shih W, Wang Y,. Two-stage adaptive design for clinical trials with survival data. Journal of Biopharmaceutical Statistics 2005; 15: 707-718.
14. Grayling M, Mander A,. Do single-arm trials have a role in Phase II development plans? 2014, Submitted.
15. Mehta C, Pocock S,. Adaptive increase in sample size when interim results are promising: A practical guide with examples. Statistics in Medicine 2011; 30: 3267-3284.
16. Emerson SS, Levin C, Emerson SC,. Comments on 'Adaptive increase in sample size when interim results are promising: A practical guide with examples'. Statistics in Medicine 2011; 30: 3285-3301.
17. Glimm E,. Comments on 'Adaptive increase in sample size when interim results are promising: A practical guide with examples' by C.R. Mehta and S.J. Pocock. Statistics in Medicine 2012; 31: 98-99.
18. Koyama T, Chen H,. Proper inference from simon's two-stage designs. Statistics in Medicine 2008; 27: 3145-3154.
19. Bauer P, Koenig F,. The reassessment of trial perspectives from interim data: a critical view. Statistics in Medicine 2006; 25: 23-36.
20. Wang M,. Sample size re-estimation by Bayesian prediction. Biometrical Journal 2007; 49: 365-377.
21. Sydes MR, Parmar MKB, James ND, Clarke NW, Dearnaley DP, Mason MD, Morgan RC, Sanders K, Royston P,. Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial. Trials 2009; 10: 39.
22. Fairbanks K, Madsen R,. P-values for tests using a repeated significance test design. Biometrika 1982; 69: 69-74.